Adnan Abdullah Balamesh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adnan Abdullah Balamesh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Abdulaziz Turki Alhadrami
College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
1 shared publicationAbdullah Abdulaziz Almuwaysi
College of Medicine, Ha’il University, Ha’il, Saudi Arabia
1 shared publication- Abdullah Abid Altuwairqi
Department of Orthopedic Surgery, King Abdulaziz University, Jeddah, Saudi Arabia
1 shared publication - Abdulmalik Ahmed Alomrani
College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Ali Alkhamis
College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia
1 shared publication - Essam Wael E Zarei
Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 13 March 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (4) , 2648-2660
Transoral endoscopic thyroidectomy vestibular approach versus open thyroidectomy in surgical resection of the thyroid: a systematic review and meta-analysis
Background: The increasing incidence of thyroid nodules and thyroid cancer, particularly among women, has driven the evolution of minimally invasive thyroidectomy techniques. The transoral endoscopic thyroidectomy vestibular approach (TOETVA) has emerged as a promising alternative to conventional open thyroidectomy (OT). This study aimed to compare operative time, blood loss, drainage volume, lymph node yield, and postoperative complications between TOETVA and OT. Methods: A comprehensive search was conducted across PubMed, Embase, ClinicalTrials.gov, and Web of Science. Randomized controlled trials, cohort studies, and retrospective studies comparing TOETVA and OT were included. Statistical analysis was performed using RevMan version 5.3. Standardized mean differences and odds ratios with 95% confidence intervals were calculated. A P -value of <0.05 was considered statistically significant. Results: A total of 22 studies involving 4397 patients were included. TOETVA was associated with a significantly longer operative time and higher drainage volume. However, no significant differences were observed in blood loss, number of retrieved central lymph nodes, metastatic lymph node yield, recurrent laryngeal nerve palsy, seroma formation, or wound infection. Conclusion: TOETVA represents a safe and feasible alternative to OT, offering comparable surgical and oncological outcomes with the added benefit of superior cosmetic results.
- 13 March 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (4) , 2648-2660
Open AccessTransoral endoscopic thyroidectomy vestibular approach versus open thyroidectomy in surgical resection of the thyroid: a systematic review and meta-analysis
Background: The increasing incidence of thyroid nodules and thyroid cancer, particularly among women, has driven the evolution of minimally invasive thyroidectomy techniques. The transoral endoscopic thyroidectomy vestibular approach (TOETVA) has emerged as a promising alternative to conventional open thyroidectomy (OT). This study aimed to compare operative time, blood loss, drainage volume, lymph node yield, and postoperative complications between TOETVA and OT. Methods: A comprehensive search was conducted across PubMed, Embase, ClinicalTrials.gov, and Web of Science. Randomized controlled trials, cohort studies, and retrospective studies comparing TOETVA and OT were included. Statistical analysis was performed using RevMan version 5.3. Standardized mean differences and odds ratios with 95% confidence intervals were calculated. A P -value of <0.05 was considered statistically significant. Results: A total of 22 studies involving 4397 patients were included. TOETVA was associated with a significantly longer operative time and higher drainage volume. However, no significant differences were observed in blood loss, number of retrieved central lymph nodes, metastatic lymph node yield, recurrent laryngeal nerve palsy, seroma formation, or wound infection. Conclusion: TOETVA represents a safe and feasible alternative to OT, offering comparable surgical and oncological outcomes with the added benefit of superior cosmetic results.